期刊论文详细信息
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 卷:91
JAAD Game Changers: Dupilumab shows long-term safety and efficacy in patients with moderate-to-severe atopic dermatitis enrolled in a phase 3 open-label extension study
Editorial Material
Wohltmann, Wendi E.1 
[1] San Antonio Mil Med Ctr, Dermatol & Pathol, 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 USA
DOI  :  10.1016/j.jaad.2019.07.074
来源: Elsevier
PDF
【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_jaad_2019_07_074.pdf 601KB PDF download
  文献评价指标  
  下载次数:312次 浏览次数:1次